Sinergium Biotech is an Argentine biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of high-complexity vaccines and biopharmaceutical products. Headquartered in Buenos Aires with a 20,000 m2 manufacturing site in Garin, it operates through an innovative productive model based on strategic alliances with national and international laboratories, including technology transfers for influenza, pneumococcal conjugate, and HPV vaccines. The company is part of an Argentine biotechnological park and advances mRNA vaccine development to help reduce imports and strengthen regional supply. Its products and processes comply with international Good Manufacturing Practice (GMP) standards and are regulated by agencies such as ANMAT, the US FDA, and the EMA.
| Import | Export |
|---|---|
|
Trade Records
405
|
Trade Records
82
|
|
Suppliers
3
|
Buyers
-
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, SINERGIUM BIOTECH S A exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
As an importer, SINERGIUM BIOTECH S A sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore SINERGIUM BIOTECH S A's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| MARCHESINI GROUP | SINERGIUM BIOTECH S A | 3926 | 24 | $186,500 | 3,420 | Los Angeles |
| GRONINGER & CO. GMBH | SINERGIUM BIOTECH S A | 7326 | 24 | $186,500 | 3,420 | Los Angeles |
| PFIZER IRELAND PHARMACEUTICALS | SINERGIUM BIOTECH S A | 2835 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into SINERGIUM BIOTECH S A's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
Chain Insights — Explore SINERGIUM BIOTECH S A's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access SINERGIUM BIOTECH S A's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.